Tag | Content |
---|
EnhancerAtlas ID | HS042-20267 |
Organism | Homo sapiens |
Tissue/cell | Fetal_brain |
Coordinate | chr17:76674090-76676270 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
SCRT1 | MA0743.1 | chr17:76674461-76674476 | GAGCAACAGGTGCAT | + | 6.52 | SCRT2 | MA0744.1 | chr17:76674461-76674474 | GAGCAACAGGTGC | + | 6.71 | SNAI2 | MA0745.2 | chr17:76674465-76674475 | AACAGGTGCA | + | 6.02 | Sox3 | MA0514.1 | chr17:76675190-76675200 | AAAACAAAGG | - | 6.02 | Stat6 | MA0520.1 | chr17:76675355-76675370 | CTTTCTCAGGAAAAC | - | 6.05 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_05030 | chr17:76674891-76676525 | Brain_Cingulate_Gyrus | SE_07013 | chr17:76675701-76676638 | Brain_Hippocampus_Middle_150 | SE_09291 | chr17:76673092-76674336 | CD14 | SE_09291 | chr17:76674647-76676767 | CD14 | SE_18275 | chr17:76674754-76676078 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH17I078676 | chr17 | 76672767 | 76675118 | GH17I078679 | chr17 | 76675227 | 76678224 |
|
Enhancer Sequence | CCCACCTCGC ACTGGGTGCA AGAAGGTTTG AGGACAGTGT GCCTGCAGAG TGCCAAAGGG 60 GGTGTCTGCA GATCCCGAGG CTGAGGCCAG CCCGCTCCGG GACAGAGCAG AGGAGTCCAG 120 CAAGCCCACA GGAGAACTTG GCACTCACGC TCATGAAAGG ATTGAATGAT TCTAAATGTG 180 ACTTTGAAAA ATGCTTAGTT TTTCTGACTA TAGAAGTAAA AACCATATGA AAGACACATG 240 TACAAAACCA GCCAAAACTG TTTTGAAAGA CCAGTGAGGG AGGACAGGGA ACTCGCCAGC 300 CAGCACAGTC AAAGGACACC ACGATGCCAC AGGGGGAGGG GCGGGCGGCG CTCACGCTGG 360 GAGGCGCGGT GGAGCAACAG GTGCATGAAG CGTGGTGGGG GAGCTGGGTA CACTCTAAGG 420 AGAGCATATG AAGTCAGTGG GGGCGATGCC AATGAATCCA TAAATGGTGT CCGGACCATC 480 AGCTATTCAT TCATGAGAAC AAACTTAAAC CCTTACTTCA AATCTTATAT AAAAAATACA 540 TTTCATAATG ATTCAATAAA TTTTTTTTTC AGTATGTTAA AAAAAAGGAT ACCGGTCCCC 600 CACAACACTG CTGTTTTCTT CCCCAGAACA CAGGGCTGGT GCCATTACTG GTAGGGGACT 660 CTGAAAACAC CGTGGCACCG CGTCTGCTCA ATGGAGGGTG GGCTGGCCCC CGCTCAGGGC 720 CACACTTCCC ATGATGGCTG TCATGCCAGG GAAGCTGCCA AACCCCATGC CCACTACACA 780 ATCTCATTTA ATCCTCAAAA GAGCCCCATG AGGCAGAAAT GACCTCTATC ACACAGAAGA 840 GGTAGGTTAC CCACCTACCA GGCACTGCGC TCAGAGAGAC AGAGCGAGGA GTCTCAGCGC 900 AGCGTGACCT GGCGCCAAAT CCATCCTCTC TCCAGCTGGT TCCTGTCTGT TTTCATTGCA 960 TGAATTTTCA GATTACTTTT GAGAGGATAA ATCATCTATT CCTTTCCCTC CATCATCACA 1020 TCATCTCCAT CTTCAGTCAG TTTTAAGGTA TTTAGCTTGG GCCAAAACCT ACACTGGTCT 1080 GAGTAGAAAT ACCAAAAGAT AAAACAAAGG CTAGAGGATA TTGCACACCC TCGGGAACGG 1140 GGCTGTAGCC TGGGTGGGAG AAAGCCCGTC ACACAGTACA CAGAGGACTT ACAGGGACCT 1200 TCGCAGTCAC CTGTGGGCAC ATTCTCCCTG TCTTCCAGGT GAAGTCACAC AGGCAGCTGA 1260 GGAGTCTTTC TCAGGAAAAC AGCTAGGTGA ACTCTCATGG ATGAAGCACC AGGAGGGAGA 1320 GGGCAAGGCT GTGCTCTTAG GAGAAAGGAT CACTGAGAGA AGGCAAAGTC AGAATGCTCA 1380 CTGCTGACCC TCGCACAGGG ACTGGAGGGA GGAGAAAGCA TCACTGAGAG AAGGCAAAGT 1440 CAGAATGCTC ACTGCTGACC CTCGCACAGG GACTGGAGGG AGAGCCAGGC AGACCAAGTC 1500 CCAGGGAAGA ACATTAAGCA AGAGAAGCCA ACTGACTTTA GAAAGCCATG TTTCCAGATA 1560 CTTGTCACAT GAGGAAATTT CCAGCCCCGT GATAGACCTT ACATGGCGTG GCCCAGTGGA 1620 GCCAACAGAG CCGAGAGGTA GGAGTCAGAG GCCTGGACTT GGGAGCTCCA CTTCTTAGCT 1680 GTGGAACCCT GAGGAAGCTT CTCCCTCCTC CCGGACCTTG GATCACGGTA TGTGACTTCC 1740 AGCAAATTTC TTAACCTCTA TGGGCCTCAG TTTCCTCATC TGTAGCTAGG AAAATGGTGT 1800 CTCACAGGAT TCACAAATTA CAGAACATGA CTACTATCTC CTCTGAGCTG TCACTATGAG 1860 AATGAGAGCG GCTTCGTCAG ACACAGAAAG ACCAGTTGAG CAGATGGCAT CTGTGTGGGT 1920 AGCTCACTCG CCTCTTCCTA TTTTGGGTCT ATGAGGACAC GTGGGGAACC CAGATGGGAC 1980 GTGCTCTCTT ACATATGCTA TAATAGCCAA GAATCCAAAG GCCTCCTGGG AAGCCGTCAG 2040 CTGGGAACCA GGACGAAGCT TCCCTAAGAA CTTGGAGCAC AGAAGAGATG CGGGCGGCAT 2100 GTTTAACCAC TAAGATGATC AACACCTGGT GAGGTGAGGG CTGCACCAGG CGCGCACTGC 2160 CCTTTCTCAG CAGTCACTTA 2180
|